|LETTER TO THE EDITOR
|Year : 2019 | Volume
| Issue : 5 | Page : 1191
Research is pivotal to fight cancer in developing countries
Cancer Registry and Epidemiology, Dr. B Borooah Cancer Institute, Guwahati, Assam; General Secretary, Cancer Research Foundation, India
|Date of Web Publication||4-Oct-2019|
Room No. 2, OPD Block, Dr. B. Borooah Cancer Institute, Gopinath Nagar, Guwahati - 781 016, Assam
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Krishnatreya M. Research is pivotal to fight cancer in developing countries. J Can Res Ther 2019;15:1191
With an ever-rising rate in the incidences and deaths due to cancer in low- and middle-income countries, cancer is now considered as a global pandemic. By 2030, the global cancer burden is expected to rise to close to 3 crore new cases and will result in 1.7 crore deaths. Cancer is killing more people than HIV/AIDS, tuberculosis, and malaria combined together. In fact, 70% of all cancer deaths occur in the developing countries, and more than 60% of the world's new cancer cases are seen in Africa, Asia, and Central and South America. One of the major reasons for the rising incidences and death rates due to cancer in low- and middle-income countries is the lack of proper access to cancer information and eventually for its prevention. Other contributing factors are inaccessibility to hospitals well equipped for cancer diagnosis, leading to late diagnosis, inadequate facilities for cancer treatment, lack of cancer screening services, and higher prevalence of tobacco consumption in the population of low-middle-income countries.
A major driving force in the battle against cancer has been the immense scientific advancements in the diagnosis and for the treatment of cancers. The continued thrust on research has been pivotal in making newer strides against this dreaded disease. Almost the major bulk of cancer research is currently being undertaken in the developed countries. One must understand that, due to difference in existing resources and varied tumor biology between populations, adopting treatment protocols developed in the developed country settings will not necessarily reproduce the desired results in the population of low-middle-income countries like India. This calls for the pressing need to conduct translational research in low- and middle-income countries, which has so far not taken off as it should have been. The combined role of oncologists, basic cancer researchers, and epidemiologists for cancer prevention and control must be stressed upon in developing countries like India.
The real success of the fight against cancer in developing countries will be obvious when general outcomes to cancer treatment and quality of life will improve considerably, the myths associated with cancer are removed from the minds of the public, and there is delivery of higher level of cancer care to each and every individual afflicted with cancers in these countries. It is time for the lawmakers, health administrators, public health specialists, oncologists, and basic cancer researchers in the developing countries to work together toward a common goal to usher an environment conducive for cancer research. Furthermore, the recent developments in the field of oncology should be conveyed to the public and lawmakers to keep the ball rolling for cancer research.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| > References|| |
Krishnatreya M. Epidemiological research on cancers by cancer registries: A view point South Asian J Cancer 2015;4:50.